Siena Biotech has selected four highly customised Tecan Freedom Evo workstations for different roles in drug development.
Built by the Tecan Integration Group (TIG), each system is claimed to have been invaluable in increasing throughput and accuracy in testing compounds as potential therapeutic drugs.
Marta Gherardi from the compound management group, said: 'We chose our Freedom Evo systems to improve throughput, customised to exactly meet our needs by TIG.
'We visited TIG and looked at all the possibilities for customisation, choosing the ones that best suited us.
'The instruments were then built in Switzerland before being integrated with our other systems on site.' Federico Cappelli from the biomolecular screening group, added: 'We are still at the early stages of setting up some of the different applications on our Freedom Evo system, and we are working on automating our Madin-Darby canine kidney (MDCK) cell-line permeability assays in collaboration with the Met Profiling Group.
'The flexibility of the system will allow us to reproduce the results already obtained by a dedicated operator, increase the throughput and minimise inter-operator variability.'
